Top 10 Medtech Deals of Q2 (Neuronetics)Top 10 Medtech Deals of Q2 (Neuronetics)

 No. 9

Name of Company: Neuronetics Inc.

Headquarters: Malvern, Pennsylvania

Product: NeuroStar transcranial magnetic stimulation therapy, which treats patients with major depressive disorder with a form of neuromodulation.

Amount Raised: $34.3 million

Investors: Accuitive Medical Ventures, GE Ventures, InterWest Partners, Investor Growth Capital, New Leaf Venture Partners, ONSET Ventures, Polaris Venture Partners, Three Arch Partners, and an undisclosed firm.

Source: MoneyTree Report and Neuronetics